Appetite enhancement (also known as "the munchies") can be described as the experience of a distinct increase in a person's sense of hunger and appetite. This results in both an increased desire to eat food and an increased enjoyment of its taste.
Appetite enhancement is most commonly induced under the influence of moderate dosages of orexigenic compounds, such as cannabinoids, mirtazapine, and quetiapine. However, it may also occur under the influence of other compounds such as GABAergic depressants, tricyclic antidepressants (TCAs), tetracyclic antidepressants, first-generation antihistamines, most antipsychotics, and many steroid hormones.
- Selective serotonin reuptake inhibitor
Anecdotal reports which describe this effect within our experience index include:
- Experience: 200µg 1P-LSD (sublingual) + 12mg CBD - The Vortex of Empathy
- Experience:1.5 Grams Psilocybe Cubensis
- Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
- Experience:3 bowls of cannabis indica - I wrote down unintelligible gibberish
- Experience:An experiement combining mangoes and cannabis
- Experience:Citalopram 10 mg and Cannabis 7 hits
- Experience:Diazepam (20/10mg, Oral) - Comfortably Drunk
- Experience:Nutmeg (8 teaspoons) - My Mom Introduces Me To Genesis and Other Things
- Experience:Unknown dose - Supermarket dislocation and biking
- Responsible use
- Subjective effects index
- Appetite suppression
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects
- Berry, E. M., Mechoulam, R. (August 2002). "Tetrahydrocannabinol and endocannabinoids in feeding and appetite". Pharmacology & Therapeutics. 95 (2): 185–190. doi:10.1016/S0163-7258(02)00257-7. ISSN 0163-7258.
- Montgomery, S. A. (1 December 1995). "Safety of mirtazapine: a review". International clinical psychopharmacology. 10 Suppl 4: 37–45. doi:10.1097/00004850-199512004-00006. ISSN 1473-5857.